BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28525371)

  • 21. Arsenic trioxide inhibits breast cancer cell growth via microRNA-328/hERG pathway in MCF-7 cells.
    Wang Y; Wang L; Yin C; An B; Hao Y; Wei T; Li L; Song G
    Mol Med Rep; 2015 Jul; 12(1):1233-8. PubMed ID: 25824027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-133b contributes to arsenic-induced apoptosis in U251 glioma cells by targeting the hERG channel.
    Wang J; Li Y; Jiang C
    J Mol Neurosci; 2015 Apr; 55(4):985-94. PubMed ID: 25355491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The rescuable function and mechanism of resveratrol on As₂O₃-induced hERG K⁺ channel deficiency.
    Zhao X; Zhang KP; Huang T; Yan CC; Liu LR; Zhu QL; Guo FF; Liu C; Li BX
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Nov; 387(11):1079-89. PubMed ID: 25107562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SUMO1 negatively regulates the transcriptional activity of EVI1 and significantly increases its co-localization with EVI1 after treatment with arsenic trioxide.
    Singh S; Pradhan AK; Chakraborty S
    Biochim Biophys Acta; 2013 Oct; 1833(10):2357-68. PubMed ID: 23770046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CACUL1/CAC1 attenuates p53 activity through PML post-translational modification.
    Fukuda T; Kigoshi-Tansho Y; Naganuma T; Kazaana A; Okajima T; Tsuruta F; Chiba T
    Biochem Biophys Res Commun; 2017 Jan; 482(4):863-869. PubMed ID: 27889610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arsenic trioxide stimulates SUMO-2/3 modification leading to RNF4-dependent proteolytic targeting of PML.
    Weisshaar SR; Keusekotten K; Krause A; Horst C; Springer HM; Göttsche K; Dohmen RJ; Praefcke GJ
    FEBS Lett; 2008 Sep; 582(21-22):3174-8. PubMed ID: 18708055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promyelocytic Leukemia Protein (PML) Requirement for Interferon-induced Global Cellular SUMOylation.
    Maroui MA; Maarifi G; McManus FP; Lamoliatte F; Thibault P; Chelbi-Alix MK
    Mol Cell Proteomics; 2018 Jun; 17(6):1196-1208. PubMed ID: 29535160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crosstalk between PML and p53 in response to TGF-β1: A new mechanism of cardiac fibroblast activation.
    Huang D; Zhao D; Li M; Chang SY; Xue YD; Xu N; Li SJ; Tang NN; Gong LL; Liu YN; Yu H; Li QS; Li PY; Liu JL; Chen HX; Liu MB; Zhang WY; Zhao XM; Lang XZ; Li ZD; Liu Y; Ma ZY; Li JM; Wang N; Tian H; Cai BZ
    Int J Biol Sci; 2023; 19(3):994-1006. PubMed ID: 36778116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ZNF198, a zinc finger protein rearranged in myeloproliferative disease, localizes to the PML nuclear bodies and interacts with SUMO-1 and PML.
    Kunapuli P; Kasyapa CS; Chin SF; Caldas C; Cowell JK
    Exp Cell Res; 2006 Nov; 312(19):3739-51. PubMed ID: 17027752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interplay of Ubiquitin-Like Modifiers Following Arsenic Trioxide Treatment.
    Rinfret Robert C; McManus FP; Lamoliatte F; Thibault P
    J Proteome Res; 2020 May; 19(5):1999-2010. PubMed ID: 32223133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TGF-β induces PML SUMOylation, degradation and PML nuclear body disruption.
    El-Asmi F; El-Mchichi B; Maroui MA; Dianoux L; Chelbi-Alix MK
    Cytokine; 2019 Aug; 120():264-272. PubMed ID: 31153006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells.
    Liu ZM; Tseng JT; Hong DY; Huang HS
    Biochem J; 2011 Sep; 438(2):349-58. PubMed ID: 21649584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of Sp1 functions by its sequestration into PML nuclear bodies.
    Li J; Zou WX; Chang KS
    PLoS One; 2014; 9(4):e94450. PubMed ID: 24728382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promyelocytic Leukemia Protein, a Protein at the Crossroad of Oxidative Stress and Metabolism.
    Tessier S; Martin-Martin N; de Thé H; Carracedo A; Lallemand-Breitenbach V
    Antioxid Redox Signal; 2017 Mar; 26(9):432-444. PubMed ID: 27758112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of Long Non-Coding RNA Kcnq1ot1: An Important Mechanism of Arsenic Trioxide-Induced Long QT Syndrome.
    Jiang Y; Du W; Chu Q; Qin Y; Tuguzbaeva G; Wang H; Li A; Li G; Li Y; Chai L; Yue E; Sun X; Wang Z; Pavlov V; Yang B; Bai Y
    Cell Physiol Biochem; 2018; 45(1):192-202. PubMed ID: 29339628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Eukaryotic expression vector pcDNA3-HERG transfection inhibits angiotensin II induced neonatal rabbit ventricular myocyte hypertrophy in vitro].
    Zhao YH; Cui CC; Li Y; Huang C
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Oct; 37(10):931-5. PubMed ID: 20137547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidative inactivation of the lipid phosphatase phosphatase and tensin homolog on chromosome ten (PTEN) as a novel mechanism of acquired long QT syndrome.
    Wan X; Dennis AT; Obejero-Paz C; Overholt JL; Heredia-Moya J; Kirk KL; Ficker E
    J Biol Chem; 2011 Jan; 286(4):2843-52. PubMed ID: 21097842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Importance of ERK activation in As2O3-induced differentiation and promyelocytic leukemia nuclear bodies formation in neuroblastoma cells.
    Petit A; Delaune A; Falluel-Morel A; Goullé JP; Vannier JP; Dubus I; Vasse M
    Pharmacol Res; 2013 Nov; 77():11-21. PubMed ID: 24004656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological inhibition of SUMO-1 with ginkgolic acid alleviates cardiac fibrosis induced by myocardial infarction in mice.
    Qiu F; Dong C; Liu Y; Shao X; Huang D; Han Y; Wang B; Liu Y; Huo R; Paulo P; Zhang ZR; Zhao D; Chu WF
    Toxicol Appl Pharmacol; 2018 Apr; 345():1-9. PubMed ID: 29524504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arsenic trioxide induces cardiac fibroblast apoptosis in vitro and in vivo by up-regulating TGF-β1 expression.
    Li C; Qu X; Xu W; Qu N; Mei L; Liu Y; Wang X; Yu X; Liu Z; Nie D; Liu Y; Yan J; Yang B; Lu Y; Chu W
    Toxicol Lett; 2013 Jun; 219(3):223-30. PubMed ID: 23542815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.